最新试用

EudraCT Number: 2005-000290-22

Sponsor Protocol Number:

Start Date: 2005-02-15

Sponsor Name: TÜ Kardioloogiakliinik

Full Title: Endoteeli funktsiooni hindamiskompleksi (pulsilaine analüüs, koronarograafia, immunohistokeemilised meetodid, biomarkerid) teaduslik väljatöötamine ja juurutamine kliinilises praktikas

Medical condition:

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male

Trial protocol: EE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2005-000040-85

Sponsor Protocol Number: HCC01

Start Date: 2005-02-15

Sponsor Name: Medical School Hannover [...] 1. Medical School Hannover 2. Medical School Hannover

Full Title: Erbitux Monotherapie bei Patienten mit lokoregional nicht behandelbarem Hepatozellulären Karzinom

Medical condition: advanced hepatocellular carcinoma (hcc) not amandable to regional therapies or metastatic disease

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2004-003616-37

Sponsor Protocol Number: M48P3

Start Date: 2005-02-15

Sponsor Name: Chiron Behring GmbH & Co KG

Full Title: M48P3: A phase IV, randomized, controlled, single-blind, multi-center study in children to evaluate the safety, tolerability and immunogenicity of two TBE vaccines administered according to two dif...

Medical condition: TBE prophylaxis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2004-003945-41

Sponsor Protocol Number: N/A

Start Date: 2005-02-15

Sponsor Name: liverpool university

Full Title: Pharmacogenetics of GABAergic mechanisms of benefit and harm in epilepsy: : A prospective cohort study to determine the enviromental and genetic factors associated with response to clobazam.

Medical condition: Epilepsy

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2004-002143-27

Sponsor Protocol Number: 1208.15

Start Date: 2005-02-15

Sponsor Name: Boehringer Ingelheim Austria GmbH

Full Title: A double-blind, stratified, randomised, parallel, placebo-controlled, multi-centre study to compare the efficacy and safety of duloxetine hydrochloride (40mg twice a day) and tolterodine tartrate (...

Medical condition: Urge Urinary Incontinence (UUI)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: AT (Completed) DK (Prematurely Ended) SE (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2004-004201-18

Sponsor Protocol Number: 0881A-101696

Start Date: 2005-02-15

Sponsor Name: Wyeth Lederle Nordiska AB

Full Title: A multicenter, open-label, randomized, pilot study to evaluate the efficacy and safety of the combination of etanercept (ETN) and methotrexate and of etanercept (ETN) alone in patients with active ...

Medical condition: Plaque psoriasis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed) DK (Completed) SE (Completed)

Trial results: View results

EudraCT Number: 2004-001183-41

Sponsor Protocol Number: D5899C00002

Start Date: 2005-02-14

Sponsor Name: AstraZeneca AB

Full Title: A 6-month, double-blind, double-dummy, randomised, parallel group, multicenter, efficacy and safety study of Symbicort® pMDI 2x160/4.5μg and 2x80/4.5μg bid compared to Formoterol Turbuhaler, Budes...

Medical condition: This is an application for a phase III study to be conducted in COPD patients.

Disease:	Version	SOC Term	Classification Code	Term	Level
			10010952

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: View results

EudraCT Number: 2004-002341-12

Sponsor Protocol Number: DEB-EPI-206

Start Date: 2005-02-14

Sponsor Name: Debiopharm SA

Full Title: Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients

Medical condition: Cystic fibrosis

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10011762		PT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: DE (Completed) GB (Completed) IT (Completed) BE (Completed)

Trial results: View results

EudraCT Number: 2004-004801-11

Sponsor Protocol Number: 04-081

Start Date: 2005-02-14

Sponsor Name: Zealand Pharma A/S

Full Title: A Phase II, Multicenter, Double-Blind, Efficacy, Safety, and Tolerability Study of ZP120 Administered as Short Term I.V. Infusion as Add-On Therapy in Patients with Subacute Decompensated Chronic H...

Medical condition: Subacute decompensated chronic heart failure NYHA Class III-IV

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-001754-92

Sponsor Protocol Number: AAE581C2201

Start Date: 2005-02-14

Sponsor Name: Novartis Pharma Services AG

Full Title: A phase II, 12-month, double-blind, placebo-controlled, dose-finding, multicenter study to evaluate the safety, tolerability, and disease modifying efficacy of daily oral AAE581 (10, 25 and 50 mg t...

Medical condition: Osteoarthritis (OA) is a disease with a complex pathophysiology leading to the degeneration of articular cartilage and bone. It is characterized by pain, biochemical and enzymatic changes, cartilag...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) IT (Completed)

Trial results: View results

最新试用

赞助者和合作者

医疗条件

药物干预